-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported November 7, 2025: Ernexa Therapeutics Q3 EPS $(0.15) Up From $(73.70) YoY

Benzinga·11/10/2025 13:51:21
Listen to the news
Ernexa Therapeutics (NASDAQ:ERNA) reported quarterly losses of $(0.15) per share. This is a 99.8 percent increase over losses of $(73.70) per share from the same period last year.